
    
      A randomized, double blind, controlled trial will be conducted in intensive care unit (ICU)
      and neurosurgery ward, in Shohada-E-Tajrish hospital,Tehran, Iran. First, patients will be
      carefully checked for inclusion and exclusion criteria. Then, the eligible patients will
      complete the consent form for this study. 60 eligible brain tumor patients diagnosed by
      surgeon that are ready for craniotomy will be selected.These patients will be divided into
      two groups. Intervention group will be received an intramuscular (IM) single dose of vitamin
      D (300000 IU),while another group will not receive. Pain in patients will be checked daily by
      up to 3 days after surgery. Finally, the VAS pain score will be compared in both groups.
    
  